Auxly Cannabis Group (CBWTF) Price Target Increased by 1,136.95% to 0.18

Analysts have revised Auxly Cannabis Group's (OTCPK:CBWTF) average one-year price target to $0.18 from $0.01 (prior estimate dated Aug 5, 2024), a 1,136.95% increase and ~714.14% above the latest close of $0.02; the latest target range is $0.18–$0.18. Institutional ownership remains minimal and unchanged over the quarter with three reporting funds holding a total of ~74K shares (Pinnacle Wealth Management Advisory Group 48K, Bard Financial Services 25K, ORG Wealth Partners 1K), suggesting limited immediate flow-driven upside despite the sizable percentage target upgrade.

Analysis

Market structure: The analyst-driven one-year target jump to $0.18 (from $0.01) creates a concentrated winner for existing Auxly (OTCPK:CBWTF) equity holders and short-term event traders; with only ~74k institutional shares and three reported funds, float is tiny so price moves will be amplified and liquidity risk is high. Competitively this does not change fundamentals for larger Canadian LPs (CGC, TLRY); instead it re-allocates speculative capital into microcap cannabis, compressing pricing power for small peers that must raise capital. Cross-asset impact is negligible at index level but expect elevated option IV on any Canadian cannabis names and episodic CAD flow if a larger financing occurs (>C$10–20m).

Key Decisions for Investors

• Establish a tactical long in CBWTF sized 0.25%–0.5% of portfolio at limit $0.02–$0.03, target $0.18 within 12 months (≈+800% upside vs current), with a hard stop-loss at $0.01 or a -50% loss relative to entry — size small due to extreme liquidity and dilution risk.
• If available, buy a 12-month call (or call spread) on CBWTF with strike ~$0.06–$0.08 amounting to no more than 0.25% portfolio risk; if options are illiquid, use a long equity + protective put (3–6 month put strike $0.01–$0.02) to cap downside.
• Execute a hedged pair: long CBWTF 0.25% vs short SNDL (SNDL) or 0.5x notional exposure to HMMJ ETF to neutralize sector beta; rebalance exposure after any company financing or coverage update.
• Do not increase exposure if Auxly issues >10% new shares or insider/institutional holdings fall by >30% in a single quarter; reassess within 2–4 weeks post any corporate announcement (financing, restructuring, delisting warning).